Copyright: ©Author(s) 2026.
World J Diabetes. Oct 15, 2026; 17(10): 123730
Published online Oct 15, 2026. doi: 10.4239/wjd.123730
Published online Oct 15, 2026. doi: 10.4239/wjd.123730
Figure 6 Effects of carnosine intervention on mitochondrial membrane potential, mitochondrial fission, and NOD-like receptor pyrin domain-containing protein 3 inflammasome activation in PC12 cells.
cP < 0.001 vs the control group; dP < 0.05, eP < 0.01, fP < 0.001 vs the high-glucose group. One-way analysis of variance with Tukey’s multiple comparisons test for Figure 6B, D-I. For Figure 6A and B, n = 5; for Figure 6C-I, n = 4. A: Representative fluorescence images of JC-1 monomers/aggregates in PC12 cells. Scale bar = 20 μm; B: Mitochondrial membrane potential level in PC12 cells; C-H: Impact on the expression levels of proteins related to mitochondrial fission and NOD-like receptor pyrin domain-containing protein 3 inflammasome activation in PC12 cells, including representative electrophoresis bands and relative expression levels; I: Enzyme-linked immunosorbent assay showing the effect on interleukin-1β expression level in PC12 cells. NLRP3: NOD-like receptor pyrin domain-containing protein 3; Drp1: Dynamin-related protein 1; HG: High-glucose; IL-1β: Interleukin-1β.
- Citation: Yu ZY, Yang J, Jiang Y, Han YZ, Wei M, Shou JY, Shen SX, Lyu YH, Li XS, Chen Q, Zhao XR, Xing GG, Ma DQ, Li M. Preventive carnosine supplementation attenuates painful diabetic neuropathy via restoring mitochondrial function and suppressing inflammasome activation. World J Diabetes 2026; 17(10): 123730
- URL: https://www.wjgnet.com/1948-9358/full/v17/i10/123730.htm
- DOI: https://dx.doi.org/10.4239/wjd.123730